… the population pharmacokinetics of piperacillin in critically ill patients with sepsis during
first dose and at steady state. The data describe significantly different pharmacokinetic …

… Therefore, we compared the population PK and pharmacodynamics (PD) of piperacillin …
received 4 g piperacillin as a 5-min intravenous infusion. We determined piperacillin levels by …

… The primary objective of this study was to explore the population pharmacokinetics of
piperacillin and tazobactam in hospitalized patients with complicated intra-abdominal infections, …

… of piperacillin/tazobactam in hospitalized obese and … -state population pharmacokinetics of
piperacillin and tazobactam, … evaluate the pharmacodynamics of piperacillin and tazobactam …

… piperacillin and tazobactam pharmacokinetic parameters during critical illness and the lack
of population pharmacokinetic … a better understanding of piperacillin/tazobactam disposition …

… This study aimed to characterize the population pharmacokinetics (PKs) of piperacillin and
investigate probability of target attainment (PTA) and cumulative fraction of response (CFR) of …

… estimates from population pharmacokinetic models based on … the population pharmacokinetics
of piperacillin when infused … piperacillin were available for population pharmacokinetic …

… changes present in this population that alter the drug’s pharmacokinetics. This review
summarizes the population pharmacokinetic models developed for piperacillin-tazobactam and …

… The study was to establish a population pharmacokinetic (PPK) model of piperacillin (PIP)
and tazobactam (TAZ) that explain pharmacokinetic variability and to propose optimized …

… There is evidence for a possible saturable elimination of piperacillin. Therefore, the … and
3,000 mg of piperacillin as 5-min intravenous infusion. Population pharmacokinetics based on …